ReviewClinical endoscopy2026
Advanced endoscopy and artificial intelligence-enabled vascular healing for ulcerative colitis: promising frontiers or mere mirage?
Review in Clinical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ulcerative colitis, a chronic inflammatory bowel disease, is characterized by subtle microvascular alterations that play a critical role in disease perpetuation and mucosal injury. Recent advances in image-enhanced endoscopy and ultrahigh-magnification endoscopy have improved the real-time visualization of these vascular changes while highlighting their diagnostic value. Artificial intelligence (AI)-enabled endoscopic systems provide automated, reproducible vascular assessments. Emerging data suggest that AI-based vascular healing correlates with clinical remission and may alter histological scores, enabling the prediction of sustained remission. Despite these promising advances, challenges remain, such as standardizing vascular healing definitions, addressing interobserver variability, and validating AI-driven platforms in real-world settings. Integrating microvascular-targeted therapies and advanced imaging has the potential to transform the management of ulcerative colitis, facilitating sustained remission and improving the quality of life. This review examined the evolving role of microvascular assessment in ulcerative colitis, the potential of AI in refining endoscopic evaluation, and the prospects of incorporating vascular healing as a therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.